DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner.
about
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyNF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsChemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cellsMonomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusionEffects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's DiseaseDimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathwaysDimethyl Fumarate: A Review in Relapsing-Remitting MS.Curcumin and insulin resistance-Molecular targets and clinical evidences.Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation.Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model.Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate.Models in the Research Process of Psoriasis.Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.The Role of Astrocytes in Multiple Sclerosis.Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge.
P2860
Q26738969-0A19C55C-12DF-4005-AC23-736F8069A88CQ28078299-E03BE16F-C08B-4C7A-840A-9FA7065D7955Q28821775-E688661F-6F01-40D8-9F2E-4C7385E56841Q36393675-C683F56B-10FA-4A0D-846C-ABE2270F1F2CQ36439880-78212156-961F-40F0-84FF-4C7B9390A7C5Q36866185-E98A880E-5236-452D-85E6-FBABFB837071Q36985371-F6FFD31A-25CA-4164-A803-DAF8E72B0683Q37091371-5709326D-1E2A-4D9C-A404-8DF5DB847F3AQ37262461-B9FC7A24-8B53-4321-82D4-5A8DC0E2983DQ37341841-15BAFD74-CC73-4672-8B9E-686ADDBB4ED6Q37620501-0780CAAE-7446-4E78-B056-D236E62FCBAAQ38675014-081F4782-B8C1-41D3-92D6-7000ADCD281DQ38871530-3D5C7580-4406-41CD-AEA5-A2C48AA60DB2Q39100528-4F472DE1-9B16-4F42-AD14-34ABEF64E5BFQ40217021-79EE863C-87C7-4B81-9D4E-79093F10F993Q42174998-5310534C-67CE-42B2-8C98-B05432C6AC76Q42229875-2992ABA8-A417-4483-AA73-7AA7CDE8DE23Q46317549-20664C7C-219A-4650-8983-9F7024468A6FQ47104079-8CAC5A1D-1194-474E-BD34-ECB93981C76FQ47181496-9F87CBCA-62D2-41A7-9316-97D778A24CFDQ48472483-054B6C66-1B3F-44C5-A63B-EDC447B73F43Q49800939-33FDCD9B-D9DE-4ACF-A0E4-BBD2967EB091Q49884884-8BE9B555-8A45-40E7-9098-FF3383E98F78Q52668332-C872F41B-B7AB-4361-B5F0-99A89602B829Q52720174-41A5470B-598A-47F6-AA1D-BF8DCA033A85Q55117400-9D6078EC-FAAB-44A8-BD9B-3091EB2626C8Q55121964-6CD51CA6-0A6B-4540-A08D-1CF0C4C677EE
P2860
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
DMF, but not other fumarates, ...... in an Nrf2-independent manner.
@en
type
label
DMF, but not other fumarates, ...... in an Nrf2-independent manner.
@en
prefLabel
DMF, but not other fumarates, ...... in an Nrf2-independent manner.
@en
P2093
P1476
DMF, but not other fumarates, ...... in an Nrf2-independent manner
@en
P2093
David J Huss
Geoffrey O Gillard
Jason D Fontenot
Jianhua Chao
John Anderson
P356
10.1016/J.JNEUROIM.2015.04.006
P577
2015-04-23T00:00:00Z